Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1977
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA ; volume:38 ; number:2 ; day:5 ; month:2 ; year:2022 ; pages:57-63 ; date:2.2022
Drugs & therapy perspectives ; 38, Heft 2 (5.2.2022), 57-63, 2.2022
- Urheber
-
Heo, Young-A
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40267-021-00888-1
- URN
-
urn:nbn:de:101:1-2022052720441104708473
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heo, Young-A
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Correction to: Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective